MétaCan
Menu
Back to cohort
Record W3013737316 · doi:10.1101/2020.03.27.20044941

Circulating insulin-like growth factor-I, total and free testosterone concentrations and prostate cancer risk in 200,000 men in UK Biobank

2020· preprint· en· W3013737316 on OpenAlexfundno aff
Eleanor L. Watts, Georgina K. Fensom, Karl Smith-Byrne, Aurora Perez‐Cornago, Naomi E. Allen, Anika Knüppel, Marc J. Gunter, Michael V. Holmes, Richard M. Martin, Neil Murphy, Konstantinos K. Tsilidis, Bu B. Yeap, Timothy J. Key, Ruth C. Travis

Bibliographic record

VenuemedRxiv · 2020
Typepreprint
Languageen
FieldMedicine
TopicProstate Cancer Treatment and Research
Canadian institutionsnot available
FundersCancer Council VictoriaMedical Research CouncilCanadian Institutes of Health ResearchNational Institutes of HealthUniversity of BristolNational Institute for Health and Care ResearchRosetrees TrustPancreatic Cancer UKEuropean CommissionProstate Cancer Foundation of AustraliaCancer Research InstituteRoyal Marsden NHS Foundation TrustNational Cancer InstituteBritish Heart FoundationNational Human Genome Research InstituteWellcome TrustProstate Cancer FoundationUniversity Hospitals Bristol NHS Foundation TrustNational Cancer Research InstituteNational Health and Medical Research CouncilCancer Research UK
KeywordsProstate cancerMendelian randomizationMedicineHazard ratioProspective cohort studyInternal medicineSex hormone-binding globulinOncologyTestosterone (patch)Proportional hazards modelCancerInsulin-like growth factorGynecologyEndocrinologyHormoneAndrogenBiologyConfidence intervalGenotypeGeneticsGenetic variantsGrowth factor

Abstract

fetched live from OpenAlex

Abstract Background Insulin-like growth factor-I (IGF-I) and testosterone have been implicated in prostate cancer aetiology. Using newly available data from a large prospective full-cohort with standardised assays and repeat blood measurements, and genetic data from an international consortium, we aimed to investigate the associations of circulating concentrations of IGF-I, sex hormone-binding globulin (SHBG), total and calculated free testosterone with prostate cancer risk. Patients and methods For prospective analyses of prostate cancer incidence and mortality, we studied 199,698 male UK Biobank participants using Cox proportional hazards models. Multivariable-adjusted hazard ratios (HRs) were corrected for regression dilution bias using repeat hormone measurements from a subsample of up to 7,776 men. A 2-sample Mendelian randomization (MR) analysis of IGF-I and risk used genetic instruments identified from UK Biobank men and genetic outcome data from 79,148 cases and 61,106 controls from the PRACTICAL consortium. We used cis - and all ( cis and trans ) SNP MR approaches. Results After a mean follow-up of 6.9 years, 5,402 men were diagnosed with and 295 died from prostate cancer. Higher circulating IGF-I was associated with an elevated risk (HR per 5 nmol/L increment=1.09, 95% CI 1.05-1.12) and prostate cancer mortality (HR per 5 nmol/L increment=1.15,1.02-1.29) in observational analyses. Cis - and all SNPs MR analyses also supported the role of IGF-I in prostate cancer diagnosis ( cis -MR odds ratio per 5 nmol/L increment=1.34,1.07-1.68). In observational analyses, higher free testosterone was associated with a higher risk of prostate cancer (HR per 50 pmol/L increment=1.10,1.05-1.15), and higher SHBG was associated with a lower risk of prostate cancer (HR per 10 nmol/L increment=0.95,0.94-0.97), but neither was associated with prostate cancer mortality. Total testosterone was not associated with prostate cancer. Conclusion(s) These findings implicate IGF-I and free testosterone in prostate cancer development and/or progression. Key message Prostate cancer is the second most common cancer in men, but modifiable risk factors have not been identified. Using large-scale prospective observational and genetic data we investigated the associations of circulating IGF-I, SHBG and testosterone with prostate cancer diagnosis and mortality. Our results implicate IGF-I and the sex hormones in prostate cancer development. Highlights Prostate cancer is the second most common cancer in men, but no modifiable risk factors are established. We examined the associations of circulating IGF-I, SHBG, total and free testosterone with prostate cancer risk in UK Biobank. Men with higher IGF-I had a higher risk of diagnosis and mortality. Mendelian randomization also supported a causal role. Men with higher free testosterone had a higher prostate cancer risk, and men with higher SHBG had a lower risk. The results implicate IGF-I and the sex hormones in prostate cancer development.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

How this classification was reachedexpand

Full frame distilled prediction

Teacher imitation

Not calibrated prevalence, not ground truth. Human validation pending. Learned from the 10,348 direct Codex labels and 10,348 direct Gemma labels. Candidate is the union of thresholded teacher heads; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels or direct frontier model labels.

metaresearch head score (Codex)0.000
metaresearch head score (Gemma)0.000
Version: codex-gemma-dda1882f352aValidation status: machine_predicted_unvalidated
Candidate categoriesMeta-epidemiology (narrow)
Consensus categoriesnone
DomainCandidate signal: none · Consensus signal: none
Study designCandidate signal: Observational · Consensus signal: Observational
GenreCandidate signal: Empirical · Consensus signal: Empirical
Teacher disagreement score0.005
Threshold uncertainty score1.000

Codex and Gemma teacher scores by category

CategoryCodexGemma
Metaresearch0.0000.000
Meta-epidemiology (narrow)0.0000.000
Meta-epidemiology (broad)0.0010.000
Bibliometrics0.0000.000
Science and technology studies0.0000.000
Scholarly communication0.0000.000
Open science0.0000.000
Research integrity0.0000.001
Insufficient payload (model declined to judge)0.0000.000

Machine scores (provisional)

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

Opus teacher head0.034
GPT teacher head0.304
Teacher spread0.270 · how far apart the two teachers sit on this one work
Validation statusscore_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Classification

machine, unvalidated

Machine predicted; a candidate call from one teacher head, not a consensus.

Study designObservational
Domainnot available
GenreEmpirical

How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".

Quick stats

Citations10
Published2020
Admission routes1
Has abstractyes

Explore more

Same venuemedRxivSame topicProstate Cancer Treatment and ResearchFrench-language works237,207